Enhancement Of Solubility Of Poorly Water-Soluble Drug By Solid Dispersion Method Formulation And Evaluation Of Rivoroxaban Capsule Dosage Form

Authors

  • Namrata P. Savant
  • T. M. Kalyankar
  • Nagoji Shinde
  • Komal B. Shinde
  • Rohan K. Kamble
  • Mayur A. Patkari
  • Varun S. Patil
  • Manjusha V. Kadam

Keywords:

Rivaroxaban, Solid Dispersion, Solvent Evaporation, anticoagulant, Polymers, BCS Class II, Solubility

Abstract


Rivaroxaban is an Antiplatelet/anticoagulant Drug used in the treatment of venous thromboembolism and belongs to the Biopharmaceutical classification system class II; hence it has a low solubility. So that the aim of this study is to enhance the solubility of the drug by solid dispersion method. Solid dispersion is nothing but the combination of two component one hydrophilic matrix and second hydrophobic drug. There are various methods are used for the preparation of solid dispersion in which solvent evaporation method used in the research. The solubility of rivaroxaban was increased by dissolving the different polymers with API using suitable solvent (Dichloromethane+ methanol) in three different ratios 1:0.5, 1:1, 1:1.5 and then this preparation kept for 24 hrs in Hot air oven to get solvent evaporate. The best polymer and ratio screening was done with the help of solubility study, the solubility study is done with the different buffers like Ph 6.8 phosphate buffer, 4.5 acetate buffer, 0.1N HCL, water with the help of UV spectrophotometer. The evaluation of final dosage form is done with the help of dissolution study in media 4.5 acetate buffer+ 0.2% SLS for about 2hrsat a specific time interval 10, 15, 30, 45, 60, 90, 120 minutes. Drug polymer compatibility study was done by different analysis like FTIR, XRD, DSC and SEM.

Downloads

Download data is not yet available.

References

1. Kumar S, Singh P. Various techniques for solubility enhancement. Rohtak (India): Department of Pharmaceutical Sciences, Maharshi Dayanand University; 2011.

2. Bryan JW. Enhancement and controlled release as synergistic tools for bioavailability enhancement. Drug Deliv Technol. 2002;2(6):1–6.

3. Limbachiya MI. Solubility enhancement techniques for poorly soluble drugs: A review. Int J Pharm Res Dev. 2011;4(4):71–86.

4. Patil MS, Godse SG, Saudagar RB. Solubility enhancement by various techniques: An overview. World J Pharm Pharm Sci. 2013;2(6):4558–4572.

5. Kushwah V, Arora S, Katona TM, Modhave D, Fröhlich E, Paudel A. Absorption modeling and food-effect prediction of rivaroxaban, a BCS class II drug orally administered as an immediate-release tablet. Pharmaceutics. 2021;13(2):283. doi:10.3390/pharmaceutics13020283.

6. Metre S, Mukesh S, Samal SK, Chand M, Sangamwar AT. Supersaturable solid self-microemulsifying drug delivery system of a poorly soluble drug: formulation, evaluation and biopharmaceutical assessment. Mol Pharm. 2018;15(2):652–668.

7. Ganesh M, Shekar BC, Madhusudan Y. Design and optimization of rivaroxaban lipid solid dispersion for dissolution enhancement using statistical experimental design. Int J Pharm Pharm Sci. 2016;10(1):1–8.

8. Kapourani A, Vardaka E, Katopodis K, Kachrimanis K, Barmpalexis P. Rivaroxaban polymeric amorphous solid dispersions: moisture-induced thermodynamic phase behavior and intermolecular interactions. Eur J Pharm Biopharm. 2019;145:98–112. doi:10.1016/j.ejpb.2019.10.010.

9. Halim T, Sohel MDD. Study of dissolution enhancement by solid dispersion technique using different polymers. J Pharm Chem Biol Sci. 2019;9(6):1–6. doi:10.29169/1927-5951.2019.09.06.6.

10. Singh G, Kaur L, Gupta GD. Enhancement of the solubility of poorly water-soluble drugs through solid dispersion: A comprehensive review. Indian J Pharm Sci. 2017;79(5):674–687.

11. Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2012;2(1):12–17.

12. Chaudhari SP, Dugar RP. Application of surfactants in solid dispersion technology for improving solubility of poorly water-soluble drugs. J Drug Deliv Sci Technol. 2017;41:68–77.

13. Rasve V, Chakraborty AK, Jain SK, Vengurlekar S. Comparative evaluation of antidiabetic activity of ethanolic leaves extract of Clematis triloba and their SMEDDS formulation in streptozotocin-induced diabetic rats. J Popul Ther Clin Pharmacol. 2022;29(4):959–971. doi:10.53555/jptcp.v29i04.2360.

14. Sridhar I, Doshi A, Joshi B, Wankhede V, Doshi J. Solid dispersions: An approach to enhance solubility of poorly water-soluble drugs. J Sci Innov Res. 2013;2(3):685–694.

15. Gurunath S, Kumar SP, Nanjwade BK, Patil PA. Amorphous solid dispersion method for improving oral bioavailability of poorly water-soluble drugs. J Pharm Res. 2013;6:476–480.

16. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water-soluble drugs. Drug Discov Today. 2007;12(23–24):1068–1075.

17. Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132. doi:10.3390/pharmaceutics11030132.

18. Jadhav YL, Parashar B, Ostwal PP, Jain MS. Solid dispersion: Solubility enhancement for poorly water-soluble drugs. Res J Pharm Technol. 2012;5(2):1–6.

19. Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech. 2010;11(2):518–527.

20. Nikghalb LA, Singh G, Singh G, Kahkeshan KF. Solid dispersion: Methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012;2(10):170–175.

.

Downloads

Published

2024-11-10

How to Cite

1.
P. Savant N, Kalyankar TM, Shinde N, B. Shinde K, K. Kamble R, A. Patkari M, et al. Enhancement Of Solubility Of Poorly Water-Soluble Drug By Solid Dispersion Method Formulation And Evaluation Of Rivoroxaban Capsule Dosage Form. J Neonatal Surg [Internet]. 2024 Nov. 10 [cited 2026 Feb. 3];13(1):1924-38. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9786

Issue

Vol. 13 (2024): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.